ATRIAL FIBRILLATION, FAMILIAL, 14
|
0.600 |
Biomarker
|
disease |
CTD_human |
|
|
|
ATRIAL FIBRILLATION, FAMILIAL, 14
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Cardiac Arrest
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Paroxysmal ventricular tachycardia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Sick Sinus Syndrome
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Syncope
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Supraventricular tachycardia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Ventricular Fibrillation
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
First degree atrioventricular block
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Right bundle branch block
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Trifascicular block
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Paroxysmal atrial fibrillation
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
ST segment elevation (finding)
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Prolonged PR interval
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
AV Block First Degree by ECG Finding
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Visual seizure
|
0.200 |
Biomarker
|
disease |
RGD |
mRNA coding for voltage-gated sodium channel beta2 subunit in rat central nervous system: cellular distribution and changes following kainate-induced seizures.
|
9672387 |
1998 |
Charcot-Marie-Tooth disease, Type 4B1
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
In addition, a search for mutations in patients affected with CMT4B as well as a refined physical localisation excludes SCN2B as the CMT4B gene.
|
9887383 |
1999 |
Otitis Media
|
0.200 |
Biomarker
|
disease |
RGD |
Suppression of epithelial ion transport transcripts during pneumococcal acute otitis media in the rat.
|
12206256 |
2002 |
Triglycerides measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection.
|
19074352 |
2008 |
ATRIAL FIBRILLATION, FAMILIAL, 14
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in sodium channel β1- and β2-subunits associated with atrial fibrillation.
|
19808477 |
2009 |
Brugada Syndrome (disorder)
|
0.510 |
Biomarker
|
disease |
CLINGEN |
Mutations in sodium channel β1- and β2-subunits associated with atrial fibrillation.
|
19808477 |
2009 |
Nodal rhythm disorder
|
0.300 |
Biomarker
|
phenotype |
CLINGEN |
Mutations in sodium channel β1- and β2-subunits associated with atrial fibrillation.
|
19808477 |
2009 |
Other specified cardiac arrhythmias
|
0.300 |
Biomarker
|
phenotype |
CLINGEN |
Mutations in sodium channel β1- and β2-subunits associated with atrial fibrillation.
|
19808477 |
2009 |
Sinus Node Dysfunction (disorder)
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Mutations in sodium channel β1- and β2-subunits associated with atrial fibrillation.
|
19808477 |
2009 |
Ectopic rhythm
|
0.300 |
Biomarker
|
phenotype |
CLINGEN |
Mutations in sodium channel β1- and β2-subunits associated with atrial fibrillation.
|
19808477 |
2009 |